HealthEquity (HQY) EBITDA margin US GAAP (year values) |
|||||||||
| FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 13.6% | 19.9% | 28.3% | 28.1% | 24.6% | 24.6% | ||
| Changes by years, y/y, % | -8pp | +6pp | +8pp | 0pp | -4pp | +3.1% | |||
HealthEquity. EBITDA margin, %
HealthEquity. EBITDA margin, changes, pp
HealthEquity (HQY) EBITDA margin US GAAP (quarter values) |
||||||||
| FY2026Q1 | FY2026Q2 | FY2026Q3 | FY2026Q4 | FY2027Q1 | LTM ? | |||
| EBITDA margin, % | ? | 37.6% | 40.3% | 37.4% | -16.1% | 29.0% | 24.6% | |
| Changes by years, y/y, % | +8pp | +5pp | +16pp | -43pp | -9pp | |||
| Changes by quarters, q/q, % | +11pp | +3pp | -3pp | -53pp | +45pp | |||